Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

June 14, 2010

Ver artículo completo

Targeting YAP and Hippo signaling pathway in liver cancer

ALAngela M. LiuInternational Network for Cancer Treatment and Research ZXZhi XuCornell University JCJinfei ChenWenzhou Medical University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

YAP is a key oncogenic driver in liver carcinogenesis and deregulation of the Hippo pathway causes tumor formation and malignancy. Targeting YAP and cognate downstream signaling targets may have clinical utility in cancer therapies.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Targeting YAP and Hippo signaling pathway in liver cancer | Synapse

Cite This Study

Liu et al. (Mon,) studied this question.

synapsesocial.com/papers/69d7457f8e958094d1b8aa5b https://doi.org/https://doi.org/10.1517/14728222.2010.499361